Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
What happens when lab personnel’s OSHA rights to access illness and injury records seemingly clash with HIPAA privacy laws?
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.
Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.
A briefing of the current requirements you can use to avoid billing and coding errors at your own lab or pathology practice.
A newly finalized local coverage determination from MAC Palmetto GBA sets out coverage criteria for two applications of these tests.
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
UDT false billing cases seem to be on the rise again, accounting for a trio of recent multimillion dollar settlements.
On April 11, the OIG approved a proposed arrangement involving the offering of free genetic tests and counseling services.
Counterfeit COVID-19 tests are being illegally imported into the US and being distributed to unsuspecting consumers across the country.